StreetAccount Summary - Trading higher/lower: EU mid-morning
Tech, media, insurance, industrials the top gainers; miners, utilities, healthcare the big laggards:
Pfizer, Valneva Lyme disease vaccine application validated by EMA for review (€2.46, 0.00)
Powered by FactSet Research Systems Inc.